Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 26282639)

Published in J Clin Oncol on August 17, 2015

Authors

Patrick G Gavin1, Nan Song1, S Rim Kim1, Katherine L Pogue-Geile1, Soonmyung Paik2

Author Affiliations

1: National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, Pittsburgh, PA.
2: National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, Pittsburgh, PA soon.paik@nsabp.org.

Articles citing this

Reply to P.G. Gavin et al. J Clin Oncol (2015) 0.75